Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Palliation of malignant ascites by the Denver peritoneovenous shunt.

Literature DB >> 6207757

Palliation of malignant ascites by the Denver peritoneovenous shunt.

Abstract

Five out of 8 Denver peritoneovenous shunts placed in 7 patients provided excellent palliation of malignant ascites. Subclinical consumptive coagulopathy was detected after placement of 6 shunts, but no patient developed overt bleeding.

Entities: Disease Species

Mesh：

Substances：
Hemoglobins

Year: 1984 PMID： 6207757 PMCID： PMC2493674

Source DB: PubMed Journal: Ann R Coll Surg Engl ISSN： 0035-8843 Impact factor: 1.891

19 in total

1. Further experience with peritoneo-venous shunt for ascites.

Authors: H H LeVeen; S Wapnick; S Grosberg; M J Kinney
Journal: Ann Surg Date: 1976-11 Impact factor: 12.969

2. Coagulopathy following peritoneovenous shunting.

Authors: M L Schwartz; W R Swaim; S B Vogel
Journal: Surgery Date: 1979-06 Impact factor: 3.982

3. Peritoneo-venous shunting for ascites.

Authors: H H Leveen; G Christoudias; M Ip; R Luft; G Falk; S Grosberg
Journal: Ann Surg Date: 1974-10 Impact factor: 12.969

4. Dissemination of tumour cells via LeVeen shunt.

Authors: B Maat; J Oosterlee; J A Spaas; H White; F B Lammes
Journal: Lancet Date: 1979-05-05 Impact factor: 79.321

5. Radionuclide assessment of peritoneo-venous shunt patency.

Authors: A Singh; J G McAfee; F D Thomas; Z D Grossman
Journal: Clin Nucl Med Date: 1979-11 Impact factor: 7.794

6. The treatment of resistant malignant ascites by insertion of a peritoneo-atrial Holter valve.

Authors: A V Pollock
Journal: Br J Surg Date: 1975-02 Impact factor: 6.939

7. Randomized prospective matched pair study comparing peritoneovenous shunt and conventional therapy in massive ascites.

Authors: S Wapnick; S J Grosberg; M I Evans
Journal: Br J Surg Date: 1979-09 Impact factor: 6.939

Palliation of malignant ascites by the Denver peritoneovenous shunt.

1. Further experience with peritoneo-venous shunt for ascites.

2. Coagulopathy following peritoneovenous shunting.

3. Peritoneo-venous shunting for ascites.

4. Dissemination of tumour cells via LeVeen shunt.

5. Radionuclide assessment of peritoneo-venous shunt patency.

6. The treatment of resistant malignant ascites by insertion of a peritoneo-atrial Holter valve.

7. Randomized prospective matched pair study comparing peritoneovenous shunt and conventional therapy in massive ascites.

8. Noninvasive determination of LeVeen shunt patency.

9. Disseminated intravascular coagulation with the peritoneovenous shunt.

10. Peritoneovenous shunting in the management of malignant ascites.

Review 1. [Peritoneovenous shunt in the treatment of therapy-refractory ascites].